Today's Market Brief: AI-Driven U.S. & Hong Kong Stock Analysis

July 29, 2026Latest

U.S. Markets

  • 指数分化：道指 +0.93%、标普 +0.13%、纳指 -0.63%
  • CXMT 上海上市引爆中国存储竞争恐慌，SNDK -14%
  • MU -8.9%、STX -8.5%，SOXX -4.8% 连跌四日
  • 康宁指引不及预期跌 12%，拖累光模块全链
  • 资金撤 AI 换防守：XLV +2.4%、XLP +2.0%、RSP +1.2%

Hong Kong

  • 恒指 +0.41% 报 25310 点，恒生科技 +0.61%
  • 南向净卖出 24.95 亿港元，抛 AI 硬件转入小米
  • 存储链重挫：ASMPT -4.2%、江丰跌超 17%
  • 小米 +6.97%，7/30 澎程发布会 N90/N70 登场
  • 科网车股撑盘：比亚迪 +4.6%、美团 +2.7%

Today's Watchlist

  • 今夜 FOMC：62% 押注维持 3.50%-3.75% 不变
  • MSFT / META 今晚财报，AI 资本开支进入交代期
  • SNDK $1000 整数关是多空生死线
  • REPL 7/30 FDA 专家会，8/2 终裁
  • 小米 7/30 晚 7 点澎程技术发布会

Deep Dives (0 names)

No deep-dive names match the current filters

Rapid Scan (2 names)

TickerCloseChangeScoreDirectionOne-line take
REPL logoREPLUS$5.35-38.01%4NeutralDown 38.01% after FDA reviewers deemed the single-arm study 'not interpretable'. RP1 is on its third filing after two complete response letters, with an advisory meeting July 30 and a decision due August 2 — a binary event bet; not participating
CAPR logoCAPRUS$6.57-6.08%4NeutralDown 6.08% with RSI at an extreme 13.2. Internal disputes over trial data analysis and statistical plans persist ahead of an FDA advisory meeting; event risk in micro-cap biotech is uncontrollable — not participating
Daily Stock Brief: AI Analysis of U.S. & HK Markets | Quant Brief